Ardelyx is a commercial-stage biopharmaceutical company that discovers, develops, and commercializes first‑in‑class medicines for patients with significant unmet medical needs. Its approved products include IBSRELA, for irritable bowel syndrome with constipation, and XPHOZAH, a phosphate absorption inhibitor for adults with chronic kidney disease on dialysis. The company is also advancing additional programs, including a Phase 3 trial for chronic idiopathic constipation and a next‑generation NHE3 inhibitor.
1
Deals
456
Views
Viewed
less than a minute ago
0
Saves
Audience tags
Sponsorship Goals
Ardelyx is a commercial-stage biopharmaceutical company that discovers, develops, and commercializes first‑in‑class medicines for patients with significant unmet medical needs. Its approved products include IBSRELA, for irritable bowel syndrome with constipation, and XPHOZAH, a phosphate absorption inhibitor for adults with chronic kidney disease on dialysis. The company is also advancing additional programs, including a Phase 3 trial for chronic idiopathic constipation and a next‑generation NHE3 inhibitor.
456
Views
0
Followers
1
Deals
Sponsorship Goals
Sponsor Details
People
People
Deals
Partners
Key Markets
Competitors
Agencies
Analytics
Log In or Sign Up Free to access sponsorship data and contacts from this brand.
Free
✓
Access exclusive brand database and sponsorship deal analytics
✓
Unlock key decision maker contacts from brands that want to reach your audience
✓
Book more meetings with potential sponsors than even before
If you currently work at this organization, click the “Do you work here?” button to request editing privileges.
This SponsorPitch page is about Ardelyx and contains information about this organization's sponsorship activity, sponsorship decision makers and sponsorship preferences. This page is not endorsed by or affiliated with Ardelyx, though it may be actively managed and updated by company representatives. If you currently work at this organization, click the Do you work here button to request management privileges. All trademarks, service marks and copyrights are property of their respective owners.